Brivera 50mg Tablet – Adjunctive Therapy for Partial-Onset Seizures in Epilepsy
Brivera 50mg Tablet – Adjunctive Therapy for Partial-Onset Seizures in Epilepsy
Brivera 50mg Tablet – Adjunctive Therapy for Partial-Onset Seizures in Epilepsy
Description
Brivera 50mg Tablet – Selective Antiepileptic for Effective Seizure Reduction
Brivera 50mg Tablet contains Brivaracetam, a targeted synaptic vesicle protein 2A (SV2A) ligand that modulates neurotransmitter release to help control partial-onset seizures in epilepsy patients. As an adjunctive treatment for adults and adolescents aged 16 years and older, it reduces seizure frequency by enhancing synaptic function without significant cognitive impairment. This prescription tablet offers high bioavailability and rapid onset, making it a reliable addition to existing antiepileptic regimens for improved seizure management and better quality of life.
